MJNA - Medical Marijuana, Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
0.107
-0.001 (-0.892%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close0.108
Open0.115
Bid0.000 x 0
Ask0.000 x 0
Day's Range0.105 - 0.115
52 Week Range0.060 - 0.190
Volume5,015,358
Avg. Volume7,768,704
Market Cap342.244M
Beta-0.30
PE Ratio (TTM)N/A
EPS (TTM)-0.008
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • PR Newswire11 hours ago

    Medical Marijuana, Inc. Subsidiary Kannaway® Featured in Prosper Magazine for Innovative Approach to the CBD Industry

    SAN DIEGO, April 26, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA) announced today that its subsidiary Kannaway, LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has been featured in Prosper: Home-Based Business Solutions, a magazine dedicated to home businesses. In the April 2018 issue, Prosper spotlights Kannaway® and the company's executive team through a series of articles and interviews that demonstrate the company's dedication to success. The issue also features the company's lineup of CBD and hemp products, including the science behind CBD and its proprietary Bi-Bong herbal blends.

  • PR Newswireyesterday

    Men's Health Features Medical Marijuana, Inc. CEO in Article on Use of Cannabis for Workout Recovery

    SAN DIEGO, April 25, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered news coverage in top U.S. consumer publication Men's Health. The April 20, 2018, article, "What You Need to Know About Using Cannabis for Workout Recovery," provides a high-level overview of what to expect when using cannabis-based recovery products for workouts. The article features the author's interview with Medical Marijuana, Inc. CEO Dr. Stuart Titus and his commentary on the use of cannabis and cannabidiol (CBD), dubbing him "Doctor Cannabis." It also highlights the Company's research and various investments in the biotech sector.

  • PR Newswire2 days ago

    Medical Marijuana, Inc. Subsidiary Kannaway® Unveils New Hempy's® Brand, Including New Responsibly Sourced Hemp Clothing, Products and Accessories

    SAN DIEGO, April 24, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), announced today that subsidiary Kannaway, LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has announced a new product line featuring Hempy's® brand of Responsibly Sourced Hemp Clothing and Accessories.  The new line is now available for purchase in Kannaway®'s online store. "We are excited to be able to offer the Hempy's brand experience to Kannaway customers," said Kannaway® CEO Blake Schroeder. Hempy's® products are for the environmentally conscious consumer and are created by using responsibly sourced hemp and organic cotton textiles.

  • PR Newswire7 days ago

    Medical Marijuana, Inc.'s CBD Products Discounted in Celebration of Cannabis Culture Holiday 4/20

    SAN DIEGO , April 19, 2018 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced that it is excited to celebrate cannabis ...

  • PR Newswire8 days ago

    Medical Marijuana, Inc. Reports Fourth Quarter and Year End 2017 Financial Results and Operational Highlights - Annual Revenue Increased 230% Over 2016

    SAN DIEGO , April 18, 2018 /PRNewswire/ --  Medical Marijuana, Inc. (OTC PINK: MJNA), the first-ever publicly traded cannabis company in the United States , today announced financial results for the quarter ...

  • PR Newswire9 days ago

    Medical Marijuana, Inc. Subsidiary Kannaway® Announces New Powder Protein Shake and Hemp Pet Products

    SAN DIEGO , April 17, 2018 /PRNewswire/ --  Medical Marijuana, Inc . (OTC: MJNA) announced today that its subsidiary Kannaway, LLC , the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical ...

  • PR Newswire13 days ago

    Medical Marijuana, Inc. Applauds New Market Opportunities for CBD, U.S. Farmers as Sen. Mitch McConnell Pushes Bill to Legalize Hemp

    SAN DIEGO, April 13, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, announced today that the Company applauds U.S. Senate Majority Leader Mitch McConnell's first public announcement of his intention to remove industrial hemp from the Controlled Substances Act with the introduction of the Hemp Farming Act of 2018. Previously, McConnell helped develop new federal and state legal permissions for hemp and even steered hemp into the 2014 Farm Bill. Now, according to McConnell's public senate announcement on Thursday, April 12, the Hemp Farming Act of 2018 would remove hemp with less than 0.3 percent of tetrahydrocannabinol (THC) from the controlled substances list.

  • Medical Marijuana, Inc. Subsidiary HempMeds® Launches New Active Relief Roll-On Product at Pittsburgh World Medical Cannabis Conference & Expo
    PR Newswire14 days ago

    Medical Marijuana, Inc. Subsidiary HempMeds® Launches New Active Relief Roll-On Product at Pittsburgh World Medical Cannabis Conference & Expo

    SAN DIEGO , April 12, 2018 /PRNewswire/ -- Medical Marijuana, Inc . (OTC: MJNA), the first publicly traded cannabis company in the United States , announced today that its subsidiary HempMeds® has released ...

  • PR Newswire15 days ago

    Medical Marijuana, Inc. Subsidiary Kannaway® to Host Largest National Convention in Company History

    The Kannaway 2018 Empower National Convention Will Celebrate the Company's 40X Growth and Announce New Product Offerings SAN DIEGO , April 11, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA) announced ...

  • PR Newswire16 days ago

    Medical Marijuana, Inc. Subsidiary HempMeds® to Sponsor and Exhibit at 2018 World Medical Cannabis Conference & Expo

    SAN DIEGO, April 10, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® is a gold sponsor of the three-day 2018 World Medical Cannabis Conference & Expo, a conference dedicated to serving the growing national medical cannabis market, on April 12-14 in Pittsburgh, PA. "We are excited to return to the World Medical Cannabis Conference & Expo again this year as both a sponsor and exhibitor," said HempMeds® President Stephen Jones. Medical Marijuana, Inc. CEO Dr. Stuart Titus will bring his expertise to this year's conference as a featured speaker for the "An Introduction to CBDs: Who Can They Help and What are Their Health Benefits?" session.

  • PR Newswire21 days ago

    Medical Marijuana, Inc. Celebrates Two-Year Anniversary of Chief Operating Officer Blake N. Schroeder, Esq. and Company's Rapid Growth

    SAN DIEGO, April 5, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced the two-year anniversary of Chief Operations Officer Blake Schroeder's employment at the company. Schroeder, who joined Medical Marijuana, Inc. and Kannaway® in March of 2016, has vast experience leading international companies, with extensive experience in the nutrition industry ranging from legal and regulatory insight to overseeing all aspects of global sales, product development, marketing, distribution and operations. In December 2017, Schroeder was promoted from Vice President of Operations to Chief Operating Officer.

  • PR Newswire22 days ago

    Medical Marijuana, Inc. and Subsidiary Kannaway® Announce March 2018 as the Largest Revenue Sales Month in Company History

    SAN DIEGO , April 4, 2018 /PRNewswire/ -- Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that both the Company and its subsidiary  ...

  • PR Newswire23 days ago

    Leading Stock Website The Motley Fool Features Medical Marijuana, Inc. as the Only Potential Publicly-Traded Winner of Hemp Farming Act of 2018

    SAN DIEGO , April 3, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced that it garnered news coverage on leading ...

  • PR Newswire24 days ago

    Top U.S. Newspaper The Washington Post Features Medical Marijuana, Inc. and Company CEO Dr. Stuart Titus

    SAN DIEGO , April 2, 2018 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced that it garnered news coverage with a feature ...

  • Say What? This GOP Senator Wants to Legalize Hemp
    Motley Fool26 days ago

    Say What? This GOP Senator Wants to Legalize Hemp

    Are Republicans changing their tune on cannabis?

  • Medical Marijuana, Inc. Flagship Product Real Scientific Hemp Oil™ Featured on CBS' The Doctors
    PR Newswire28 days ago

    Medical Marijuana, Inc. Flagship Product Real Scientific Hemp Oil™ Featured on CBS' The Doctors

    SAN DIEGO , March 29, 2018 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced that its flagship product Real Scientific ...

  • Medical Marijuana, Inc. Subsidiary HempMeds® Brazil Provides CBD for University Study in Brazil
    PR Newswire29 days ago

    Medical Marijuana, Inc. Subsidiary HempMeds® Brazil Provides CBD for University Study in Brazil

    SAN DIEGO, March 28, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced the success of its subsidiary HempMeds® Brazil's Cannabis Symposium in Rio Grande do Sul, Brazil. There, Dr. Stuart Titus, CEO of Medical Marijuana, Inc., spoke about the benefits of cannabidiol (CBD) and also discussed upcoming potential research opportunities in Brazil. During the symposium, the Lutheran University of Brazil (Ulbra) announced its intent to begin research to evaluate the use of CBD in patients with Parkinson's disease in partnership with Dr. Kelson James Almeida, neurologist and current technical director of the Integrated Rehabilitation Center (CEIR), according to Brazilian newspaper GaúchaZH.

  • PR Newswirelast month

    Data Points to the Growth in Value of the Legal Cannabis Market

    According to data published by Energias Market Research, the global medical cannabis market is anticipated to grow significantly from USD 8.28 billion in 2017 to USD 28.07 billion by 2024 and at a CAGR of 19.1% over the forecast period. Factors driving the growth of the legal cannabis industry include mounting recognition of medical benefits, growing demand for cannabis in the treatment of various diseases, and increasing number of research and development activities. In the U.S, there are 28 states that have approved the use of cannabis for medical purposes.

  • PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary Phyto Animal Health Announces Launch of New E-Commerce Website

    "Phyto Animal Health is excited for this new milestone. Consumers can now purchase our products on the web for the first time ever," said Phyto Animal Health CEO Ian Quinn. Located at https://phytoanimalhealth.com/, Phyto Animal Health's new e-commerce site allows consumers to not only browse and shop for the company's industry leading cannabidiol (CBD) pet products, but also sign up for the company's newsletter to receive new alerts and updates about the company and new products.

  • PR Newswirelast month

    Emmy® Award-Winning Daytime Talk Show CBS' The Doctors Features Medical Marijuana, Inc. Flagship Product Real Scientific Hemp Oil™

    SAN DIEGO , March 26, 2018 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced that its flagship product Real Scientific ...

  • PR Newswirelast month

    Medical Marijuana, Inc. and Subsidiary Phyto Animal Health Featured in Top Veterinary Trade Publication

    SAN DIEGO, March 20, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary Phyto Animal Health has garnered news coverage in a top veterinary trade publication, American Veterinarian. A March 13, 2018, article on the American Veterinarian website entitled "Phyto Animal Health's Line of CBD Pet Products," features interviews with executive members of the  Phyto Animal Health Veterinary Advisory Board, Liz Hughston, MEd., RVT, CVT, VTS (SAIM, ECC), and Stephen F. Cital, RVT, SRA, RLAT, VTS-Lab Animal. The article, which includes a video interview, outlines how Phyto Animal Health products are made of the highest quality cannabidiol (CBD) hemp oil products available on the market because of the Company's laboratory testing procedures – which ensure that the products are pure and have a wide variety of terpenoids and flavonoids.

  • PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary Dixie Botanicals® Announces New Fruit-Flavored Energy Kicks

    SAN DIEGO, March 15, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, announced today that its subsidiary Dixie Botanicals® has released two new flavors of its popular Kicks CBD hemp oil energy chews. Formulated to capitalize on the balancing effects of CBD, Dixie Botanicals® Kicks, now available in two new flavors, Sour Apple and Citrus Mango, are the healthy way to give yourself a boost of energy when you're on the go. "The company is pleased to offer new flavors of our best-selling Dixie Botanicals Kicks," said Medical Marijuana, Inc. CEO Dr. Stuart Titus.

  • PR Newswirelast month

    Medical Marijuana, Inc. Subsidiary HempMeds® Brazil and ANUC Host First-Ever Hospital Cannabis Events on the Benefits of CBD in Rio Grande do Sul, Brazil

    SAN DIEGO, March 14, 2018 /PRNewswire/ -- Medical Marijuana, Inc. (MJNA), the first publicly traded cannabis company in the United States, today announced that its subsidiary HempMeds® Brazil, which was the first company authorized by Anvisa to import a cannabidiol-based product to Brazil, is partnering with the National Association of Cannabidiol Users (ANUC) to host the Cannabidiol (CBD) Symposium from March 19-23 in Rio Grande do Sul, in the cities of Canoas, Passo Fundo and Porto Alegre. It is the first time that hospitals in Brazil have ever offered cannabis events to the medical community. On March 19, Dr. Jorge Luiz Winckler, Regent Professor of Neurology at ULBRA, is hosting an evening lecture at the University of Canoas on his clinical study on CBD as a treatment for Parkinson's patients.

  • PR Newswirelast month

    Medical Marijuana, Inc. and Subsidiary HempMeds® Mexico Featured in Top 30 U.S. Market Newspaper for Role in Legalizing Mexico Market

    SAN DIEGO , March 13, 2018 /PRNewswire/ --  Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States , today announced that it has garnered news coverage in ...

  • PR Newswire2 months ago

    Medical Marijuana, Inc. and Subsidiary Kannaway® Announce February 2018 as the Largest Revenue Sales Month in Company History

    SAN DIEGO , March 6, 2018 /PRNewswire/ --  Medical Marijuana, Inc.  (OTC: MJNA), the first-ever publicly traded cannabis company in the United States , today announced that both the Company and its subsidiary  ...